ArticleActa pharmaceutica Sinica. B2024

Discovery of a novel exceptionally potent and orally active Nur77 ligand NB1 with a distinct binding mode for cancer therapy.

Jun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.